See the Presenting Company schedule and additional program highlights at http://www.biocentury.com/Data/NewsCenter2/Conferences/ConferencesFiles/NM13schedule.pdf.
Sponsors Demonstrate Long-Term Commitment to Industry
The NewsMakers 2013 sponsors are anchored by Gold Sponsors Brinson Patrick, L.E.K Consulting LLC, and WBB Securities LLC. They are joined by Silver Sponsor AstraZeneca plc.
Future BioCentury Conferences
NewsMakers is one of two premier investor conferences organized annually by BioCentury in New York. The next conference, the 21st Future Leaders in the Biotech Industry, will take place in New York City on March 28, 2014. Future Leaders connects leading portfolio managers, bankers, analysts and business development professionals with investor-validated, milestone-rich private and public companies in key therapeutic areas.
BioCentury also is a co-organizer of the upcoming SciBX Summit on Innovation in Drug Discovery & Development, to be held in Boston on October 30, 2013. The SciBX Summit is a groundbreaking conference that brings together key stakeholders from academia, biotech, pharma and the investment community to create roadmaps for solving critical translational issues in important emerging areas of drug discovery and development. This year's conference will spotlight epigenetics, CAR-based cellular therapies, non-coding RNAs and new models and in neurological disease. For more information and to register, please go to http://www.biocentury.com/conferences/scibxsummit/dates.
BioCentury also co-organizes BioEUR quity Europe, which will take place in Amsterdam, May 21 - 22, 2014. BioEUR quity Europe is the premier event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for business development and licensing professionals from pharmaceutical companies to assess top partnering and licensing prospects.
Since 1993, BioCentury Publications, Inc. has provided essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, regulators and public policy makers, and the scientific community. This audience has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, data products and collaborative industry conferences in the U.S., Europe and Asia.
BioCentury's titles include the flagship BioCentury®, the Bernstein Report on BioBusiness; its SciBX: Science-Business eXchange™ translational science partnership with Nature Publishing Group; and its BioCentury Extra™ online daily newspaper. These timely journals are backed by BCIQ: BioCentury Online Intelligence™, an online business intelligence resource. BioCentury also produces its BioCentury This Week healthcare public affairs television program in partnership with the Gannett-owned WUSA CBS affiliate in Washington, D.C. The program is aired in the nation's capital every week as part of the WUSA*9 Sunday Morning Power Block, on Public Broadcasting System member stations in selected markets and is always available globally online at www.biocenturytv.com.
For more information, visit www.biocentury.com and www.biocenturytv.com.
Source: BioCentury Publications, Inc.